blinatumomab,dasatinib,ponatinib
otsuka,amgen,takeda,astellas,incyte,bms
['equate', 'blina ', 'leusm', 'blinatumomab', 'ponatinib', 'ph+ all', 'dasatinib', 'leukemia', '2018']
#ash22 #leusm short: ponatinib + blin as frontline therapy in ph+ b-all. ponatinib starts 30mg and drops to 15mg at cmr. 5 cycles of blin. ponatinib for &gt;=5 years. 
Assoc Professor, UCSF hematology/BMT. Translational researcher interested in leukemia, MDS, MRD, post-HCT relapse, GVHD, & immune recon. Photos: pyknosis (IG)